Almost Three Decades of Post-Marketing Experience With A Human Intravenous Immunoglobulin 5%: Analysis of A Proprietary Pharmacovigilance Database

Background: Intravenous immunoglobulin (IVIg) therapies are widely used for replacement and immunomodulatory indications but are associated with known risks of adverse drug reactions (ADRs), underscoring the importance of long-term, product-specific safety surveillance. Objective: This analysis eval...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Davide Susini, MSc, Roberto Crea, DVM, MSc, Paolo Morabito, MD, Aaron Kleyn, PhD, Alessandro Bizzarri, MSc
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Elsevier 2026-06-01
coleção:	Current Therapeutic Research
Assuntos:	Adverse drug reaction Intravenous immunoglobulin Pharmacovigilance Post-marketing surveillance Safety database
Acesso em linha:	http://www.sciencedirect.com/science/article/pii/S0011393X2600007X
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!